Erratum
for
Gordon et al., J Clin Oncol 24 (26) 4324-4332.
Journal of Clinical Oncology, Vol 26, No 16 (June 1), 2008: pp. 2793
© 2008 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2008.17.6867
ERRATUM
The September 10, 2006, article by Gordon et al entitled, "Clinical Activity of Pertuzumab (rhuMAb 2C4), a HER Dimerization Inhibitor, in Advanced Ovarian Cancer: Potential Predictive Relationship With Tumor HER2 Activation Status" (J Clin Oncol 24:4324-4332, 2006) contained errors.
In Table 3, the data were incorrectly given for Survival and Progression Free Survival. The corrected table is reprinted below in its entirety. The online version has been corrected in departure from the print.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
|